These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 308390)

  • 41. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
    Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
    Ahrlund-Richter L; Klein E; Merino F
    Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
    Chang RW; Turk JL
    Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.
    Evans R; Booth CG; Spencer F
    Br J Cancer; 1978 Nov; 38(5):583-90. PubMed ID: 310310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
    Gautam SC; Deodhar SD
    Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules.
    Flood PM; DeLeo AB; Old LJ; Gershon RK
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1683-7. PubMed ID: 6220407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
    Crowe NY; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
    Bhatnagar RM; Zabriskie JB; Rausen AR
    J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.
    Chapdelaine JM; Plata F; Lilly F
    J Exp Med; 1979 Jun; 149(6):1531-6. PubMed ID: 221614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody response of mice to chemically induced tumors.
    Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 56. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL.
    Schirrmacher V; Garrido F; Hübsch D; Garcia-Olivares E; Koszinowski U
    Transplant Proc; 1980 Mar; 12(1):32-7. PubMed ID: 6154357
    [No Abstract]   [Full Text] [Related]  

  • 57. Delayed cutaneous hypersensitivity reaction to tumor-specific antigens of fibrosarcoma in sensitized mice.
    Milas L; Dekaris D; Horvat M
    Experientia; 1970 Nov; 26(11):1248-9. PubMed ID: 5485300
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 59. Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.
    Kall MA; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5086-9. PubMed ID: 1082135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.